Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen: a prospective cohort study

OBJECTIVE: Recycling tenofovir and lamivudine/emtricitabine (XTC) with dolutegravir would provide a more tolerable, affordable, and scalable second-line regimen than dolutegravir with an optimized nucleoside reverse transcriptase inhibitor (NRTI) backbone. We evaluated efficacy of tenofovir/lamivudi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:AIDS
Asıl Yazarlar: Keene, Claire M, Griesel, Rulan, Zhao, Ying, Gcwabe, Zimasa, Sayed, Kaneez, Hill, Andrew, Cassidy, Tali, Ngwenya, Olina, Jackson, Amanda, Van Zyl, Gert, Schutz, Charlotte, Goliath, Rene, Flowers, Tracy, Goemaere, Eric, Wiesner, Lubbe, Simmons, Bryony, Maartens, Gary, Meintjes, Graeme
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7612028/
https://ncbi.nlm.nih.gov/pubmed/33973876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002936
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller